An evaluation of a medication management training programme for community mental health professionals; service user level outcomes: a cluster randomised controlled trial

Int J Nurs Stud. 2009 May;46(5):645-52. doi: 10.1016/j.ijnurstu.2008.10.010. Epub 2008 Dec 13.

Abstract

Background: Antipsychotic treatment is important in reducing symptomatology and relapse in schizophrenia. Community mental health professionals (CMHPs) have a significant role in this treatment; however, evidence suggests that many are ineffective in medication management.

Objectives: To develop and evaluate a medication management training programme whose aims are to increase the effectiveness of pharmacological treatment and increase services users' involvement in treatment decisions.

Participants: Twenty-eight pairs of CMHPs were recruited from mental health Trusts in England. For each practitioner an average of 3.4 service users were randomly selected for their 'study caseload'.

Design: A pragmatic cluster randomised trial assessed the service users of CMHPs allocated to medication management training or waiting list controls.

Methods: All practitioner participants were taught to use a variety of assessment measures and undertook baseline assessments with their service users. The experimental practitioners then attended the training programme. At the 9-month endpoint the service users were re-assessed.

Results: After the outcome data was adjusted for clustering the trained practitioners made significant improvements in global psychopathology and service user involvement in treatment when compared to controls at 9 months.

Conclusions: Training CMHPs in medication management has a positive impact on clinical outcomes and service user involvement in treatment.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Cluster Analysis
  • Community Mental Health Services*
  • Humans
  • Mental Disorders / drug therapy*
  • Outcome Assessment, Health Care*
  • Workforce

Substances

  • Antipsychotic Agents